LATEST NEWS

KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH

Nov 11, 2023

previous: ASX Today: Stocks to watch on Thursday

Borterra’s new RodBot boosts drilling productivity :next

Name: *

E-mail: *

Phone/WhatsApp: *

Subject: *

Content: *

Send to us